HFA Premium Access

Plasma adrenomedullin and risk of heart failure in people with type 2 diabetes: the Surdiagene and Diabhycar prospective studies

Congress Presentation

About the speaker

Doctor Barnabas Gellen

Polyclinic of Poitiers Elsan, Poitiers (France)
1 presentation
0 follower

13 more presentations in this session

Predictors of left ventricular hypertrophy in hypertensive patients. Data from SEPHAR III study.

Speaker: Associate Professor R. Darabont (Bucharest, RO)


A description of characteristics of very elderly patients newly diagnosed with heart failure: a retrospective population-based cohort study in Sweden

Speaker: Professor M. Olofsson (Skelleftea, SE)


Elamipretide, a cardiolipin-targeting peptide, decreases mitochondrial oxidant stress in the failing human heart

Speaker: Doctor B. Stauffer (Aurora, US)


Sex, reverse remodeling and prognosis in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)


The clinical meaning of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction

Speaker: Assistant Professor A. Bielecka-Dabrowa (Lodz, PL)


Access the full session

Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis

Speakers: Doctor B. Gellen, Associate Professor R. Darabont, Professor M. Olofsson, Doctor B. Stauffer, Doctor A. Aimo...

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb